MAP Pharmaceuticals, Inc.
Expanded development agreement for asthma, other respiratory therapies signed
Published in Genetics and Environmental Business Week, August 25th, 2005
MAP has been collaborating with Elan to develop a nebulized form of budesonide for the treatment of asthma. The agreement provides additional rights to MAP for the use of NanoCrystal technology for the treatment of multiple respiratory diseases, including asthma.
This agreement covers nebulized delivery of budesonide and combinations of budesonide with beta agonists. Budesonide is an anti-inflammatory corticosteroid...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
More Articles from Genetics and Environmental Business Week
- Align Technology, Inc.
Medical device maker optimizes operations, reduces costs in consolidation - CuraGen Corp.
Genomics-focused pharma reports Q2 loss of $15.7 million - DOR BioPharma, Inc.
Agreement inked with Dow for BT-VACC for botulinum toxin poisoning - Lexicon Genetics Inc.
Biopharmaceutical company reports Q2 29% revenue growth over prior year - NeoGenomics, Inc.
Clinical testing laboratory announces results for second quarter - Pharmion Corporation
Pharma company announces second quarter 2005 results - More from this issue of Genetics and Environmental Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
